Organisation paid for research Program year 2025 Source: CMS Open Payments

Ctca Clinical Research Inc.

Neither a doctor nor a teaching hospital

Research payments

$2,142,655

353 payments

Through program year 2025, Ctca Clinical Research Inc. is reported as receiving $2,142,655 in research payments, across 353 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$2,556	7
2024	Research	$1,158	1
2023	Research	$17,541	9
2022	Research	$244,820	69
2021	Research	$206,546	120
2020	Research	$511,409	106
2019	Research	$1,158,625	41

Breakdown

Who paid Research payments · program years 2019–2025

Daiichi Sankyo Inc. $1,349,925 230 payments
Daiichi Sankyo Company LTD $681,542 28 payments
BeiGene, Ltd. $111,188 95 payments

Studies the money was for Research payments · program years 2019–2025

U31402-A-J101 $626,028 24 payments
Study name not reported $602,506 22 payments
Study name not reported $290,833 40 payments
Ds8201-A-U303 $220,611 79 payments
U31402-A-J101 $134,127 27 payments
Ds8201-A-U303 $115,493 47 payments
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Clinical Study Comparing the Efficacy and Safety of Tislelizumab (BGB-A317) Plus Platinum and Fluoropyrimidine Versus Placebo Plus Platinum and Fluoropyrimidine as First-Line Treatment in Patients Wi $111,188 95 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.